Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN04119516
ISRCTN04119516
Completed
Phase 3

Phase III randomised controlled trial of a breathlessness intervention service for intractable breathlessness

Cambridge University Hospitals NHS Foundation Trust (UK)0 sites120 target enrollmentDecember 18, 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsRespiratoryIntractable breathlessness, malignant and non-malignant conditionsAbnormalities of breathing

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Respiratory
Sponsor
Cambridge University Hospitals NHS Foundation Trust (UK)
Enrollment
120
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

2011 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/21599896 protocol 2014 Results article in http://www.ncbi.nlm.nih.gov/pubmed/25358424 results 2016 Results article in http://www.ncbi.nlm.nih.gov/pubmed/27044249 results

Registry
who.int
Start Date
December 18, 2008
End Date
April 30, 2011
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •For patients:
  • •1\. Appropriate referral to BIS
  • •2\. Aged 18 years or older, either sex
  • •3\. Any patient not meeting any exclusion criteria
  • •For carers:
  • •1\. Informal carers (significant others, relatives, friends or neighbours) of phase III recruits
  • •2\. Aged 18 years or older, either sex
  • •3\. Any carer not meeting any exclusion criteria

Exclusion Criteria

  • •Patients/carers:
  • •1\. Unable to give informed consent
  • •2\. Previously used BIS
  • •3\. Demented/confused
  • •4\. Learning difficulties
  • •5\. Other vulnerable groups for example head injury, severe trauma, mental illness
  • •6\. Not meeting all inclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
A randomised phase III clinical trial investigating the effect of Fragmin® added to standard therapy In patients with lung cancer
ISRCTN80812769Velindre NHS Trust (UK)2,202
Completed
Not Applicable
Perioperative management of antiplatelet agents in general and visceral surgery: a pilot studySurgical complication rates, thromboembolic eventsNot Applicable
ISRCTN45810007niversity Hospital Heidelberg (Universitätsklinikum Heidelberg) (Germany)50
Active, not recruiting
Not Applicable
A study to test a package of support to help women who have stopped smoking while pregnant to stay smoke-free after giving birth
ISRCTN70307341niversity of East Anglia880
Completed
Not Applicable
Study of the effectiveness of breathing training exercises taught by a physiotherapist by either instructional videos/DVDs/internet download or by face to face sessions in the management of asthma in adultsAsthmaRespiratory
ISRCTN88318003niversity of Aberdeen (UK)585
Completed
Phase 4
Intensified treatment for tuberculous meningitis to reduce mortalityTuberculosis of nervous systemTuberculous meningitisInfections and Infestations
ISRCTN61649292niversity of Oxford (UK)817